Temsirolimus and Irinotecan for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations (TIRASMUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00827684
Recruitment Status : Completed
First Posted : January 23, 2009
Last Update Posted : June 8, 2011
Information provided by:
Vejle Hospital

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2011
  Study Completion Date : June 2011